Cryo-Cell
CCEL
P/S ratio for Cryo-Cell (CCEL)
P/S ratio as of April 2024 (TTM): 2.18
According to Cryo-Cell's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.1849. At the end of 2023 the company had a P/S ratio of 1.54.
P/S ratio history for Cryo-Cell from 2001 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 1.54 | 22.18% |
| 2022 | 1.26 | -65.43% |
| 2021 | 3.66 | 101.21% |
| 2020 | 1.82 | 1.94% |
| 2019 | 1.78 | -8.8% |
| 2018 | 1.95 | -13.34% |
| 2017 | 2.26 | 80.76% |
| 2016 | 1.25 | -11.5% |
| 2015 | 1.41 | 4.61% |
| 2014 | 1.35 | 28.57% |
| 2013 | 1.05 | -33% |
| 2012 | 1.56 | 42.46% |
| 2011 | 1.10 | -24.64% |
| 2010 | 1.46 | 24.34% |
| 2009 | 1.17 | 197.08% |
| 2008 | 0.3944 | -53.54% |
| 2007 | 0.8490 | -50.79% |
| 2006 | 1.73 | -39.92% |
| 2005 | 2.87 | 14.12% |
| 2004 | 2.52 | 77.92% |
| 2003 | 1.41 | -53.68% |
| 2002 | 3.05 | -75.67% |
| 2001 | 12.5 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Omnicell
OMCL | 1.11 | -48.98% | 🇺🇸 USA |
 Global Cord Blood CORBF | 0.8635 | -60.48% | 🇭🇰 Hong Kong |
 CorVel Corporation
CRVL | 5.28 | 141.49% | 🇺🇸 USA |